Literature DB >> 9080304

Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin.

A K Khanna1, Y Nomura, V A Fischetti, J B Zabriskie.   

Abstract

Previous work from this laboratory has demonstrated the occurrence of heart reactive antibodies (HRA) in the sera of acute rheumatic fever (ARF) patients which bound primarily to the sarcolemmal sheath of cardiac myofibres. While many investigators have reported the presence of antibodies to myosin in the sera of ARF patients, the question of whether these sera also contain antibodies to other cytoskeletal proteins has not been addressed. In this study, crude human sarcolemmal sheaths were extracted with 3 M KCl and partially purified using a DEAE cellulose column and a step gradient of NaCl. Maximum reactivity with ARF sera was seen with a protein fraction eluted with 0.3 M NaCl. Using FPLC, a single polypeptide of 38 kDa reacted in ELISA preferentially with ARF sera when compared to sera from patients with uncomplicated streptococcal infections and acute post-streptococcal glomerulonephritis (APSGN). A comparison of the N-terminal sequence of the purified protein and competitive inhibition assays indicated that the reactive sarcolemmal antigen was human cardiac tropomyosin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9080304     DOI: 10.1006/jaut.1996.0107

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.

Authors:  L Guilherme; S E Oshiro; K C Faé; E Cunha-Neto; G Renesto; A C Goldberg; A C Tanaka; P M Pomerantzeff; M H Kiss; C Silva; F Guzman; M E Patarroyo; S Southwood; A Sette; J Kalil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 2.  Vertebrate tropomyosin: distribution, properties and function.

Authors:  S V Perry
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

3.  Immunogenic and Genetic Factors in Rheumatic Fever.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

4.  Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study.

Authors:  K F Jones; S S Whitehead; M W Cunningham; V A Fischetti
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.

Authors:  Xavier M Teitsma; Jenny Devenport; Johannes W G Jacobs; Attila Pethö-Schramm; Michelle E A Borm; Petra Budde; Johannes W J Bijlsma; Floris P J G Lafeber
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.